A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation

Hypertension Research

Volumn 37, Issue 6, 2014, Pages 519-525

  Hirashima, Chikako ^a   Ohkuchi, Akihide ^a   Takahashi, Kayo ^a   Suzuki, Hirotada ^a   Matsubara, Shigeki ^a   Suzuki, Mitsuaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

angiogenesis factor; blood pressure; prediction; preeclampsia

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN;

ADULT; ARTICLE; AUTOMATED ELECTROCHEMILUMINESCENCE IMMUNOASSAY; BIRTH WEIGHT; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL HISTORY; NEWBORN; NULLIPARA; OBESITY; ONSET AGE; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL SCREENING; PROTEINURIA; PUERPERIUM; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; UTERINE ARTERY; BLOOD; BLOOD EXAMINATION; EVALUATION STUDY; MASS SCREENING; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROCEDURES; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; HEMATOLOGIC TESTS; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84902012418     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.31     Document Type: Article

References (21)

1. Shiozaki A, Matsuda Y, Satoh S, Saito S. Impact of fetal sex in pregnancy-inducedhypertension and preeclampsia in Japan. J Reprod Immunol 2011; 89: 133-139.
2. Nagaya K, Fetters MD, Ishikawa M, Kubo T, Koyanagi T, Saito Y, Sameshima H, Sugimoto M, Takagi K, Chiba Y, Honda H, Mukubo M, Kawamura M, Satoh S, Neki R.Causes of maternal mortality in Japan. JAMA 2000; 283: 2661-2667.
3. Yamauchi A, Minakami H, Ohkuchi A, Usui R, Idei S, Sato I. Causes of stillbirth: ananalysis of 77 cases. J Obstet Gynaecol Res 1999; 25: 419-424.
4. Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y, Suzuki M. Threshold ofsoluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onsetof preeclampsia. Hypertension 2011; 58: 859-866.
5. Pedrosa AC, Matias A. Screening for preeclampsia: a systematic review of tests combininguterine artery Doppler with other markers. J Perinat Med 2011; 39: 619-635.
6. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R. Identification of patients at risk for earlyonset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry andplacental growth factor. Am J Obstet Gynecol 2007; 196: e1-13.
7. Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenicfactors in second trimester pregnancies with abnormal uterine perfusion. Hypertension2007; 49: 818-824.
8. Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for theprediction of preeclampsia in women with abnormal mid trimester uterine arteryDoppler velocimetry. Int J Gynaecol Obstet 2008; 102: 146-151.
9. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction ofhypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.
10. Jaeschke R, Guyatt GH, Sackett DL. Uers' guides to the medical literature. III. How touse an article about a diagnostic test. B. What are the results and will they help me incaring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271: 703-707.
11. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic reviewof screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367-1391.
12. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.Circulating angiogenic factors and the risk of preeclampsia. New Engl J Med 2004;350: 672-683.
13. Ohkuchi A, Iwasaki R, Suzuki H, Hirashima C, Takahashi K, Usui R, Matsubara S, Minakami H, Suzuki M. Normal and high-normal blood pressures, but not body massindex, are risk factors for the subsequent occurrence of both preeclampsia and gestationalhypertension: a retrospective cohort study. Hypertens Res 2006; 29: 161-167.
14. Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M. Ruling a diagnosis inor out with "SpPIn" and "SnNOut": a note of caution. BMJ 2004; 329: 209-213.
15. Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, Suzuki M.Evaluation of a new and automated electrochemiluminescence immunoassay forplasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res 2010;33: 422-427.
16. Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, Matsubara S, Suzuki M. Onsetthreshold of plasma levels of soluble fms-like tyrosine kinase 1/placental growth factorratio for predicting imminent onset of preeclampsia within 4 weeks after bloodsampling at 19 to 31 weeks of gestation. Hypertens Res 2013; 36: 1073-1080.
17. Takahashi K, Ohkuchi A, Hirashima C, Matsubara S, Suzuki M. Establishing referencevalues for mean notch depth index, pulsatility index and resistance index in the uterineartery at 16-23 weeks' gestation. J Obstet Gynaecol Res 2012; 38: 1275-1285.
18. Ohkuchi A, Minakami H, Sato I, Mori H, Nakano T, Tateno M. Predicting the risk ofpreeclampsia and a small-for-gestational-age infant by quantitative assessment of thediastolic notch in uterine artery flow velocity waveforms in unselected women.Ultrasound Obstet Gynecol 2000; 16: 171-178.
19. Sato K. A proposal for a new definition and classification of "pregnancy inducedhypertension (PIH)" (2004). In: Japan Society for the Study of Toxemia of Pregnancy(eds). Historical Perspective of Study of Pregnancy-Induced Hypertension in Japan.Medical View Co, Tokyo, Japan, 2005, pp 54-87.
20. Ogawa Y, Iwamura T, Kuriya N, Kuriya N, Nishida H, Takeuchi H, Yakada M, Itabashi K, Imura S, Isobe K. Birth size standards by gestational age for Japanese neonates. ActaNeonatol Jpn 1998; 34: 624-632.
21. Confidence interval calculator [Computer Program]. Available at http://www.pedro.org.au/english/downloads/confidence-interval-calculator/. (Accessed 30 September 2012.).